FDA Global Panel Focuses On Developing Countries’ Reg Systems
This article was originally published in The Rose Sheet
Executive Summary
An FDA Science Board subcommittee will assess safety awareness in countries exporting food and medical products to the U.S. and identify potential strategies for strengthening regulatory systems in those countries, says Chairman Jeff Bender.
You may also be interested in...
Congress Instructs FDA On Nanotech Work, But Mute On Funding
Newly passed user-fee legislation includes a provision directing FDA to intensify its research and policy development regarding nanotechnology and its use in consumer products. How such efforts are to be funded remains a question.
Louis Jacques On Coverage, Evidence And IDEs
Former CMS coverage director Louis Jacques talks about the strong future ahead he envisions for the Medicare coverage-with-evidence-development program and new coverage policies that will be implemented for investigational device exemption trials.
Reimbursement Briefs: Pfizer Joins Big Data Group; Part D Protected Classes; Wikipedia Partners With Cochrane Collaboration
Pfizer is among seven organizations joining the Optum Labs research collaborative; CMS Coverage and Analysis Group Director Louis Jacques moving to private sector, more news in brief.